Rathod Virender P Singh, Kapoor Prem, Pillai K K, Khanam Razia
Department of Pharmacology, Faculty of Pharmacy, Majeedia Hospital, Jamia Hamdard University, New Delhi - 110 062, India.
J Pharm Bioallied Sci. 2010 Oct;2(4):337-40. doi: 10.4103/0975-7406.72136.
The physiological and clinical similarities between asthma and chronic obstructive pulmonary disorder (COPD) make their differentiation difficult. In the present study, we compared reversibility to bronchodilator, immunoglobulin E (IgE), blood eosinophil and neutrophil levels among asthma and COPD patients to differentiate these diseases.
The study was carried on 20 asthmatics and 29 patients of COPD that reported to the outpatient and inpatient department in University Teaching Hospital, Jamia Hamdard, New Delhi, India. The parameters evaluated included pulmonary function (FEV(1), FVC, and FEV(1)/FVC), IgE levels, and eosinophil and neutrophil count.
It was observed that reversibility was significantly higher in asthmatic patients, while irreversibility predominates in COPD patients. There was no significant difference in pre- and post-FEV(1) and pre- and post-FVC and in their percentage predicted. However the percentage change in FEV(1) significantly varies in asthma and COPD patients. No significant changes in neutrophil and eosinophil levels were observed in these patients. The serum IgE levels were found significantly higher in asthmatic patients.
We conclude that reversibility in FEV(1) levels or percentage change in FEV(1) and serum IgE levels are promising lab parameter to distinguish these two conditions. However, further research is required to fully understand the role of neutrophil and eosinophil in the onset and development of asthma and COPD.
哮喘与慢性阻塞性肺疾病(COPD)在生理和临床方面存在相似之处,这使得二者难以区分。在本研究中,我们比较了哮喘患者和COPD患者对支气管扩张剂的反应性、免疫球蛋白E(IgE)、血液嗜酸性粒细胞和中性粒细胞水平,以鉴别这两种疾病。
该研究对印度新德里贾米亚·哈马德大学教学医院门诊和住院部的20例哮喘患者和29例COPD患者进行。评估的参数包括肺功能(第一秒用力呼气容积(FEV₁)、用力肺活量(FVC)和FEV₁/FVC)、IgE水平以及嗜酸性粒细胞和中性粒细胞计数。
观察到哮喘患者的反应性显著更高,而COPD患者则以不可逆性为主。FEV₁前后、FVC前后及其预测百分比均无显著差异。然而,哮喘患者和COPD患者的FEV₁百分比变化显著不同。这些患者的中性粒细胞和嗜酸性粒细胞水平未观察到显著变化。哮喘患者的血清IgE水平显著更高。
我们得出结论,FEV₁水平的反应性或FEV₁百分比变化以及血清IgE水平是区分这两种疾病的有前景的实验室参数。然而,需要进一步研究以充分了解中性粒细胞和嗜酸性粒细胞在哮喘和COPD发病及发展中的作用。